GUYER CHARLES GREG (EVP, Chief Technical Officer) received a stock award from BIOMARIN PHARMACEUTICAL INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/17/2026ACC: 0001628280-26-019012
Officer· EVP, Chief Technical Officer
Since May 2020
+41.56K
Net shares
Net buyer
$533.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
50.67K acquired · 9.11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.11K
Price / share
$58.51
Trade value
$532.97K
% of position
11.4%
3/13/2026
79.95K→70.84K
Common Stock
Direct
Shares
+14.99K
Price / share
—
Trade value
—
% of position
21.2%
3/16/2026
70.84K→85.83K
Total
Net shares
+5.88K
Net value
-$532.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | F · Tax Withholding | −9.11K | $58.51 | $532.97K | 11.4% | 79.95K | 70.84K |
| Common Stock Direct | 3/16/2026 | A · Award | +14.99K | — | — | 21.2% | 70.84K | 85.83K |
| Total | +5.88K | -$532.97K | ||||||
Derivative Transactions1
Stock Option (Right to Buy Common Stock)
Direct
Converts to
Common Stock
35.68K shares
Shares
+35.68K
Strike price
57.43
Held after
35.68K
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock) Direct | Common Stock35.68K shares | 3/16/2026 | A · Award | +35.68K | 57.43 | — | 35.68K |